In vitro activities of the β-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with β-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains

被引:96
作者
Higgins, PG [1 ]
Wisplinghoff, H [1 ]
Stefanik, D [1 ]
Seifert, H [1 ]
机构
[1] Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50935 Cologne, Germany
关键词
D O I
10.1128/AAC.48.5.1586-1592.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Acinetobacter baumannii is an important nosocomial pathogen usually in the context of serious underlying disease. Multidrug resistance in these organisms is frequent. The beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam have intrinsic activity against Acinetobacter strains. To evaluate their potential therapeutic usefulness, we determined the in vitro activity of ampicillin, sulbactam, ampicillin-sulbactam, cefoperazone, cefoperazone-sulbactam, piperacillin, piperacillin-sulbactam, tazobactam, piperacillin-tazobactam, amoxicillin, clavulanic acid, amoxicillin-clavulanic acid, ticarcillin, and ticarcillin-clavulanic acid against multidrug-resistant A. baumannii. All isolates were epidemiologically characterized by RAPD [random(ly) amplified polymorphic DNA] analysis and/or pulsed-field gel electrophoresis and represented different strain types, including sporadic strains, as well as outbreak-related strains. The MICs were determined by agar dilution on Mueller-Hinton agar (using fixed concentrations, as well as fixed ratios for beta-lactamase inhibitors) and the E-test. The majority of E-test results were within two dilutions of those recorded by agar dilution, with the exception of piperacillin-tazobactam. Sulbactam was superior to clavulanic acid and tazobactam and may represent an alternative treatment option for infections due to multiresistant A. baumannii strains. beta-Lactamase inhibitors have intrinsic activity but do not enhance activity of beta-lactams against A. baumannii. Testing with the inhibitor added at a fixed concentration as recommended for piperacillin-tazobactam and ticarcillin-clavulanic acid by the National Committee for Clinical Laboratory Standards may falsely suggest high activity or gives uninterpretable results due to trailing. If combinations are used for testing, fixed ratios may give more useful results.
引用
收藏
页码:1586 / 1592
页数:7
相关论文
共 33 条
[1]   SUSCEPTIBILITY SURVEY OF PIPERACILLIN ALONE AND IN THE PRESENCE OF TAZOBACTAM [J].
ACAR, JF ;
GOLDSTEIN, FW ;
KITZIS, MD .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 :23-28
[2]   Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii [J].
Afzal-Shah, M ;
Woodford, N ;
Livermore, DM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) :583-588
[3]   Antibiotic susceptibility patterns of community-acquired respiratory isolates of Moraxella catarrhalis in Western Europe and in the USA [J].
Berk, SL ;
Kalbfleisch, JH .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 :85-96
[4]   IDENTIFICATION AND BIOTYPING OF CLINICAL ISOLATES OF ACINETOBACTER [J].
BOUVET, PJM ;
GRIMONT, PAD .
ANNALES DE L INSTITUT PASTEUR-MICROBIOLOGIE, 1987, 138 (05) :569-578
[5]   Imipenem resistance among Acinetobacter baumannii: Association with reduced expression of a 33-36 kDa outer membrane protein [J].
Clark, RB .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (02) :245-251
[6]   Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii [J].
Corbella, X ;
Ariza, J ;
Ardanuy, C ;
Vuelta, M ;
Tubau, F ;
Sora, M ;
Pujol, M ;
Gudiol, F .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (06) :793-802
[7]   AMANTADINE PROPHYLAXIS FOR HEALTH-CARE WORKERS - UNANSWERED QUESTIONS [J].
COX, RA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 (01) :1-3
[8]  
*DTSCH IND NORM ME, 2001, 989404 DIN
[9]   Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients:: Geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999) [J].
Gales, AC ;
Jones, RN ;
Forward, KR ;
Liñares, J ;
Sader, HS ;
Verhoef, J .
CLINICAL INFECTIOUS DISEASES, 2001, 32 :S104-S113
[10]   Multicenter study using standardized protocols and reagents for evaluation of reproducibility of PCR-based fingerprinting of Acinetobacter spp. [J].
Grundmann, HJ ;
Towner, KJ ;
Dijkshoorn, L ;
GernerSmidt, P ;
Maher, M ;
Seifert, H ;
Vaneechoutte, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (12) :3071-3077